{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T06:17:11Z","timestamp":1788675431172,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,27]]},"DOI":"10.7759\/cureus.79771","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T18:14:31Z","timestamp":1740680071000},"source":"Crossref","is-referenced-by-count":2,"title":["Beyond Acute Overdoses: A Case of Chronic Clozapine Toxicity With Non-specific Presentation"],"prefix":"10.7759","author":[{"given":"Shahzad","family":"Dildar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ali","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane J","year":"1988","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988, 45:789-96. 10.1001\/archpsyc.1988.01800330013001","journal-title":"Arch Gen Psychiatry"},{"key":"ref2","article-title":"Socio demographic, clinical, and side effect profile of patients on clozapine in Kashmir, North India","volume":"28","author":"Nazir D","year":"2021","unstructured":"Nazir D, Wani ZA, Bukhari F, Dar SA, Kawoosa Y. Socio demographic, clinical, and side effect profile of patients on clozapine in Kashmir, North India. MECP. 2021, 28:82.","journal-title":"MECP"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200108000-00005","article-title":"Myocarditis related to clozapine treatment","volume":"21","author":"H\u00e4gg S","year":"2001","unstructured":"H\u00e4gg S, Spigset O, Bate A, Soderstr\u00f6m TG. Myocarditis related to clozapine treatment. J Clin Psychopharmacol. 2001, 21:382-8. 10.1097\/00004714-200108000-00005","journal-title":"J Clin Psychopharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2003.tb05310.x","article-title":"Managing patients with \"treatment-resistant\" schizophrenia","volume":"178","author":"Pantelis C","year":"2003","unstructured":"Pantelis C, Lambert TJ. Managing patients with \"treatment-resistant\" schizophrenia. Med J Aust. 2003, 178:S62-6. 10.5694\/j.1326-5377.2003.tb05310.x","journal-title":"Med J Aust"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-015-0578-7","article-title":"An evaluation of variation in published estimates of schizophrenia prevalence from 1990\u25002013: a systematic literature review","volume":"15","author":"Simeone JC","year":"2015","unstructured":"Simeone JC, Ward AJ, Rotella P, Collins J, Windisch R. An evaluation of variation in published estimates of schizophrenia prevalence from 1990\u25002013: a systematic literature review. BMC Psychiatry. 2015, 15:193. 10.1186\/s12888-015-0578-7","journal-title":"BMC Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23082087","article-title":"Current concepts and treatments of schizophrenia","volume":"23","author":"St\u0119pnicki P","year":"2018","unstructured":"St\u0119pnicki P, Kondej M, Kaczor AA. Current concepts and treatments of schizophrenia. Molecules. 2018, 23:2087. 10.3390\/molecules23082087","journal-title":"Molecules"},{"key":"ref7","article-title":"Fluvoxamine increases the clozapine serum levels significantly","volume":"6","author":"Koponen HJ","year":"1996","unstructured":"Koponen HJ, Leinonen E, Lepola U. Fluvoxamine increases the clozapine serum levels significantly. ENP. 1996, 6:69-71.","journal-title":"ENP"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1039856214559041","article-title":"A clozapine conundrum: clozapine toxicity in an acute medical illness","volume":"22","author":"Matthews CJ","year":"2014","unstructured":"Matthews CJ, Hall TL. A clozapine conundrum: clozapine toxicity in an acute medical illness. Australas Psychiatry. 2014, 22:543-5. 10.1177\/1039856214559041","journal-title":"Australas Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103017002014","article-title":"Serum clozapine levels: a review of their clinical utility","volume":"17","author":"Greenwood-Smith C","year":"2003","unstructured":"Greenwood-Smith C, Lubman DI, Castle DJ. Serum clozapine levels: a review of their clinical utility. J Psychopharmacol. 2003, 17:234-8. 10.1177\/0269881103017002014","journal-title":"J Psychopharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14851","article-title":"Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database","volume":"87","author":"Montastruc JL","year":"2021","unstructured":"Montastruc JL, Lafaurie M, de Canecaude C, Durrieu G, Sommet A, Montastruc F, Bagheri H. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database. Br J Clin Pharmacol. 2021, 87:4334-40. 10.1111\/bcp.14851","journal-title":"Br J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbz093","article-title":"Data from the World Health Organization\u2019s pharmacovigilance database supports the prominent role of pneumonia in mortality associated with clozapine adverse drug reactions","volume":"46","author":"De Leon J","year":"2020","unstructured":"De Leon J, Sanz EJ, De Las Cuevas C. Data from the World Health Organization\u2019s pharmacovigilance database supports the prominent role of pneumonia in mortality associated with clozapine adverse drug reactions. Schizophr Bull. 2020, 46:1-3. 10.1093\/schbul\/sbz093","journal-title":"Schizophr Bull"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245249","article-title":"Extrapyramidal side effects of clozapine and haloperidol","volume":"118","author":"Kurz M","year":"1995","unstructured":"Kurz M, Hummer M, Oberbauer H, Fleischhacker WW. Extrapyramidal side effects of clozapine and haloperidol. Psychopharmacology (Berl). 1995, 118:52-6. 10.1007\/BF02245249","journal-title":"Psychopharmacology (Berl)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245620","article-title":"Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects","volume":"124","author":"Peacock L","year":"1996","unstructured":"Peacock L, Solgaard T, Lublin H, Gerlach J. Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects. Psychopharmacology (Berl). 1996, 124:188-96. 10.1007\/BF02245620","journal-title":"Psychopharmacology (Berl)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2012.8.1.15","article-title":"Drug-induced parkinsonism","volume":"8","author":"Shin HW","year":"2012","unstructured":"Shin HW, Chung SJ. Drug-induced parkinsonism. J Clin Neurol. 2012, 8:15-21. 10.3988\/jcn.2012.8.1.15","journal-title":"J Clin Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10082010","article-title":"Pathophysiological mechanisms of antipsychotic-induced parkinsonism","volume":"10","author":"Vaiman EE","year":"2022","unstructured":"Vaiman EE, Shnayder NA, Khasanova AK, et al.. Pathophysiological mechanisms of antipsychotic-induced parkinsonism. Biomedicines. 2022, 10:2010. 10.3390\/biomedicines10082010","journal-title":"Biomedicines"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis","volume":"158","author":"Kapur S","year":"2001","unstructured":"Kapur S, Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry. 2001, 158:360-9.","journal-title":"Am J Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/342133-beyond-acute-overdoses-a-case-of-chronic-clozapine-toxicity-with-non-specific-presentation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T18:14:32Z","timestamp":1740680072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/342133-beyond-acute-overdoses-a-case-of-chronic-clozapine-toxicity-with-non-specific-presentation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.79771","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}